Abstract: A multi-channel parallel optical communication module includes a casing having an airtight cavity, an optical communication assembly accommodated in the airtight cavity, and a temperature controller in thermal contact with the optical communication assembly. The optical communication assembly includes a plurality of optical communication units disposed at same level, and a number of the plurality of optical communication units is greater than four.

Abstract: An optical emitting device includes a base, a thermoelectric cooler, an optical communication assembly and a circuit board. The base includes a main body and a stem connected with each other. The stem extends from a basal surface of the main body, and a normal of a supporting surface of the stem is non-parallel to a normal of the basal surface of the main body. The thermoelectric cooler is disposed on the supporting surface of the stem. The optical communication assembly is disposed on the thermoelectric cooler, and the thermoelectric cooler is between the optical communication assembly and the stem. The circuit board is disposed on the base and passes through the main body and electrically connected with the optical communication assembly.

Abstract: An electronic device such as a wearable electronic device may have a band. The band may form a stand-alone device or a strap for a wristwatch unit or other device. Electrical components may be mounted on flexible printed circuit substrates. A substrate may be encapsulated by elastomeric polymer material or other material forming the band. The elastomeric polymer material may form cavities that receive the electrical components. Components such as light-emitting diodes may be mounted to the flexible printed circuit substrates so that the light-emitting diodes are located in the cavities. Reflective sidewalls in the cavities may reflect light from the light-emitting diodes outwardly through a thinned portion of the band. Light-diffusing material in the cavities may be formed from clear polymer with light-scattering particles.

Abstract: A system can include a multi-material fluid having a mixture of a first material and a second material. The system can also include a first vessel into which the multi-material fluid is disposed. The system can further include a first sonication device disposed, at least in part, in the multi-material fluid in the first vessel. The first sonication device, when operating, can emit ultrasound waves into the multi-material fluid. The ultrasound waves separate the first material and the second material from each other in the first vessel.

Abstract: Related to an optical communication module, the optical communication module comprises a main body, an optical communication assembly and a second circuit board. The main body comprises a housing and a first circuit board disposed on the housing. The housing and the first circuit board together form an airtight cavity of the main body, and the first circuit board comprises two first electric interfaces. The optical communication assembly is accommodated in the airtight cavity and comprises a substrate, an optical communication element and a second electric interface. The optical communication element disposed on the substrate. One of the two first electric interfaces of the first circuit board is electrically connected to the second electric interface. The second circuit board comprises a third electric interface and the other one of the two first electric interfaces of the first circuit board is electrically connected to the third electric interface.

Abstract: The present invention relates to a chemokine expressing cell. Said cell expresses an exogenous IL-21R binding protein or an exogenous IL-21 and an exogenous chemokine. Further provided is a cell expressing an exogenous receptor, an exogenous IL-21R binding protein or an exogenous IL-21 and an exogenous chemokine. The cell involved is not only effective in solid tumor cells in vitro, but also has an excellent killing effect on solid tumor cells in vivo.

Abstract: The present disclosure provides a high-flux sensor suitable for corrosion big data monitoring and a method of manufacturing the same. The sensor includes a first metal sheet, a second metal sheet and an insulating sheet therebetween. The two metal sheets are laminated. The metal sheets and the insulating sheet form a test piece group. A through hole is drilled in the test piece group.

Abstract: A system can include a multi-material fluid having a mixture of a first material and a second material. The system can also include a first vessel into which the multi-material fluid is disposed. The system can further include a first sonication device disposed, at least in part, in the multi-material fluid in the first vessel. The first sonication device, when operating, can emit ultrasound waves into the multi-material fluid. The ultrasound waves separate the first material and the second material from each other in the first vessel.

Abstract: Methods, systems, and devices for wireless communications are described. A wireless node may determine a configuration for interference measurement at the first wireless node, which may indicate a set of uplink resources for uplink reference signals and a beam sweeping configuration. Additionally, or alternatively, the configuration may indicate one or more resource sets configured for interference measurement. In some cases, the first wireless node may determine a set of transmission beams for the uplink reference signals based on the beam sweeping configuration, and the first wireless node may transmit the uplink reference signals via all of the transmission beams supported by the first wireless node.

Abstract: Disclosed in the present invention is a genetically engineered cell, expressing an exogenous receptor that specifically binds to a target antigen and exogenous CCL21, and capable of further expressing an IL-7R binding protein or exogenous IL-7 that promotes cell proliferation. Also disclosed are an expression construct comprising an exogenous CCL21 expression cassette, and a vector containing same, a virus, and a pharmaceutical composition comprising said cell. Also disclosed is an application for the cell, the expression construct, the vector, and the virus in the preparation of drugs for inhibiting tumours or inhibiting pathogens.

Abstract: A hybrid transmitter includes a current-mode driver, a voltage-mode driver and an auxiliary driver. The current-mode driver is configured to perform a current transmission. The voltage-mode driver is configured to perform a voltage transmission. The auxiliary driver, coupled to the current-mode driver and the voltage-mode driver, is configured to cooperate with the current-mode driver to enhance a driving capability of the current transmission and cooperate with the voltage-mode driver to enhance a driving capability of the voltage transmission.

Abstract: Method and apparatus for electronic detection and determination includes detecting a signal T0 in a detection zone and a signal R0 in a reference zone before a sample is added; adding a sample and detecting the signals in each of the detection zone and the reference zone at an interval of a second preset period; calculating a judgement value based on 2k immediately previous signals in each of the detection zone and the reference zone, the signal T0 in the detection zone before the sample is added, and the signal R0 in the reference zone before the sample is added, each time when k successive signals are detected in each of the detection zone and the reference zone; and determining a judgement result based on m successive judgement values and a preset result threshold corresponding to a current detection time.

Abstract: The present invention discloses a dynamic diagnosis system and method for concrete damage based on a distributed sensing optical fiber.

Abstract: Provided is an amino pyrazolopyrimidine compound as represented by the following structural formula used as a neurotrophic factor tyrosine kinase receptor inhibitor. The compound can inhibit the activity of Trk kinase and can treat diseases mediated by a Trk tyrosine kinase receptor in mammals.

Abstract: A binary vector and the provision of expression of a target antigen-dependent regulatory cytokine using the synNotch technology, so as to partially release the cytokine to enhance the function of T cell and reduce the non-specific toxic and side effect of the cytokine. A synthetic notch receptor is used to construct plasmid vectors to achieve local cytokine secretion. One plasmid vector uses a specific antibody as an extracellular domain for identifying a target antigen, a notch core comprises a transmembrane domain and a specific enzyme cutting site on a notch receptor, and transcription factor GAL4VP64 is used as an intracellular domain. When the target antigen is identified, the enzyme cutting site on the notch will be identified by a corresponding enzyme to hydrolyze and cut the intercellular transcription factor GAL4VP64.

Abstract: A combination lock comprises a lock body, a key lock assembly and a digital combination lock assembly, wherein the key lock assembly includes a lock cylinder and a locking hook sleeve, the lock body is internally provided with an indicating rod and a slider, a first inclined surface is disposed at the bottom of the indicating rod, and the slider is provided with a second inclined surface and a third inclined surface; the locking hook sleeve is provided with a fourth inclined surface; and the lock body is provided with an indicating hole, and the indicating rod can protrude upward from the lock body under the pushing action of the slider. Whether the lock has been unlocked can be judged by the indicating rod.

Abstract: Disclosed are compounds having formulae I and II or pharmaceutically acceptable salts or hydrates thereof, a preparation method thereof and pharmaceutical compositions thereof. The compounds having formulae I and II possesses an isocitrate dehydrogenase 2 (IDH2) inhibitory activity and are capable of treating IDH2 mutation-induced cancers.

Abstract: The disclosure provides a compilation method and system for heterogeneous computing platform, and a runtime method and system for supporting program execution on the heterogeneous computing platform. Inputting a trained neural network model to a Neural Network (NN) optimizing compiler to generate an NN assembly file corresponding to the neural network; inputting the NN assembly file to an NN assembler to generate an NN binary file corresponding to the neural network; compilation and assembling a neural network application developed by users in a high-level language using a host compiler toolchain to generate a corresponding host assembly file and a host binary file in sequence; and linking the NN binary file and the host binary file using a host linker to generate a single hybrid linking executable file. The technical solution of the present disclosure has the advantages such as good computing performance, strong scalability, strong compatibility and high flexibility.

Abstract: An electronic device such as a wearable electronic device may have a band. The band may form a stand-alone device or a strap for a wristwatch unit or other device. Electrical components may be mounted on flexible printed circuit substrates. A substrate may be encapsulated by elastomeric polymer material or other material forming the band. The elastomeric polymer material may form cavities that receive the electrical components. Components such as light-emitting diodes may be mounted to the flexible printed circuit substrates so that the light-emitting diodes are located in the cavities. Reflective sidewalls in the cavities may reflect light from the light-emitting diodes outwardly through a thinned portion of the band. Light-diffusing material in the cavities may be formed from clear polymer with light-scattering particles.

Abstract: Disclosed are compounds having formulae I and II or pharmaceutically acceptable salts or hydrates thereof, a preparation method thereof and pharmaceutical compositions thereof. The compounds having formulae I and II possesses an isocitrate dehydrogenase 2 (IDH2) inhibitory activity and are capable of treating IDH2 mutation-induced cancers.